Consideration of alternative licensing procedures for vaccines for minor species, minor indications and autogenous/autologous productsJONES, P. G. H.Developments in biologicals. 2004, Vol 117, pp 153-158, issn 1424-6074, 6 p.Conference Paper

The WHO Vaccine Trial RegistryROBERTSON, Susan E; MAYANS, Marti Vall; EL-HUSSEINY, Amro et al.Vaccine. 2001, Vol 20, Num 1-2, pp 31-41, issn 0264-410XArticle

Conceptual and experimental approaches to address product safety issues raised by novel cell substrates. DiscussionKRAUSE, P. R; RUBIN, Harry; FRIED, Michael et al.Developments in biologicals. 2001, Vol 106, pp 45-50, issn 1424-6074Conference Paper

Perspectives on sustainable vaccine introductionHINMAN, Alan R.Vaccine. 2013, Vol 31, issn 0264-410X, C8-C9, SUP3Article

Bases des recommandations vaccinales : Vaccination préventive et approches innovantes = Basis for vaccine recommendationsLEVY-BRUHL, Daniel.MS. Médecine sciences. 2007, Vol 23, Num 4, pp 404-408, issn 0767-0974, 5 p.Article

Vaccine use and abuse: A practitioner's viewpointMOORE, G. A.Developments in biologicals. 2004, Vol 117, pp 123-128, issn 1424-6074, 6 p.Conference Paper

Otites récidivantes et vaccinsCOHEN, R.Médecine & enfance. 2003, Vol 23, Num 7, pp 423-428, issn 0291-0233, 4 p.Article

Vaccines and sera through plant biotechnologyKOPROWSKI, Hilary.Vaccine. 2005, Vol 23, Num 15, pp 1757-1763, issn 0264-410X, 7 p.Conference Paper

Characterization of polyvalent allogeneic vaccinesVAN EPPS, D.Developments in biologicals. 2004, Vol 116, pp 79-90, issn 1424-6074, 12 p.Conference Paper

Autogenous vaccines: Industry proposals for procedures and requirementsZÄNKER, S.Developments in biologicals. 2004, Vol 117, pp 27-30, issn 1424-6074, 4 p.Conference Paper

Injectable silicone implants as vaccine delivery vehiclesLOFTHOUSE, S. A; KAJIHARA, M; NAGAHARA, S et al.Vaccine. 2002, Vol 20, Num 13-14, pp 1725-1732, issn 0264-410XArticle

Impact of osmolality on burning sensations during and immediately after intramuscular injection of 0.5 ml of vaccine suspensions in healthy adultsNONY, P; GIRARD, P; CHABAUD, S et al.Vaccine. 2001, Vol 19, Num 27, pp 3645-3651, issn 0264-410XArticle

Primum non nocere in vaccinologyBURGIO, G. R; MARSEGLIA, G. L.Vaccine. Supplement. 2001, Vol 20, pp S55-S57, issn 1359-5938Conference Paper

The current challenges for vaccine development : Vaccines and AdjuvantsOYSTON, Petra; ROBINSON, Karen.Journal of medical microbiology. 2012, Vol 61, Num 7, pp 889-894, issn 0022-2615, 6 p.Conference Paper

Diagnostic and Vaccine ChapterWOLFRAM, J. H; KOKANOV, S. K; VERKHOVSKY, O. A et al.Vaccine. Supplement. 2010, Vol 28, Num 5, issn 1359-5938, F49-F53Conference Paper

Vaccins et professions exposées : Vaccination préventive et approches innovantes = Vaccines and exposed occupationsGENDREL, Dominique.MS. Médecine sciences. 2007, Vol 23, Num 4, pp 417-422, issn 0767-0974, 6 p.Article

Autogenous vaccines: Current use patterns and end users' needs in the integrated broiler industrySMITH, J. A.Developments in biologicals. 2004, Vol 117, pp 63-67, issn 1424-6074, 5 p.Conference Paper

Harmonisation of regulatory requirements for veterinary vaccinesJONES, P. G. H.Developments in biologicals. 2004, Vol 119, issn 1424-6074, p. 371Conference Paper

Recombinant BCG vaccinesOHARA, Naoya; YAMADA, Takeshi.Vaccine. 2001, Vol 19, Num 30, pp 4089-4098, issn 0264-410XArticle

Response to HBV vaccine in relation to vaccine dose and anti-HCV positivity: A New South Wales correctional facilities' studyAWOFESO, Niyi; LEVY, Michael; HARPER, Susan et al.Vaccine. 2001, Vol 19, Num 30, pp 4245-4248, issn 0264-410XArticle

Vaccins polysaccharidiques = Polysaccharidic vaccinesAJJAN, N.Revue de pédiatrie (Paris). 1990, Vol 26, Num 1, pp 9-22, issn 0035-1644, 14 p.Article

Peptidi sintetici immunogeni = Peptides immunogènes synthétiques = Synthetic immunogenic peptidesPIETTA, P.Chimica oggi. 1985, Num 10, pp 11-14, issn 0392-839XArticle

Technical transformation of biodefense vaccinesSHAN LU; SHIXIA WANG.Vaccine. Supplement. 2009, Vol 27, Num 4, issn 1359-5938, D8-D15Article

Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive AdultsKENNEDY, Jeffrey S; GURWITH, Marc; YOKOTE, Hiroyuki et al.The Journal of infectious diseases. 2011, Vol 204, Num 9, pp 1395-1402, issn 0022-1899, 8 p.Article

Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations : Undiluted and diluted lancy-vaxina vaccine in a single-blind, randomized, prospective trialKIM, Sung-Han; YEO, Sang-Gu; CHO, Haewol et al.The Journal of infectious diseases. 2005, Vol 192, Num 6, pp 1066-1070, issn 0022-1899, 5 p.Article